Delivery Order SPE2DB22D1002-SPE2DB24FLHN0

Award Date 9/6/24
Potential Completion Date 9/27/24
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML. The delivery order is valued at $3,756.72 and has a firm fixed-price pricing structure. The ultimate completion date for this contract is August 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,205.58, is for the delivery of HYPERRAB 300 UNIT/ML VIAL 3ML medical products. It is a firm fixed price contract with a completion date of July 15, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The order is for $8,996.48 worth of HYPERRAB 300 UNIT/ML VIAL 3ML pharmaceutical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency, for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML. The contract has a firm fixed price, has no set-aside designation, and has a ceiling value of $32,264.46. The period of performance extends to June 13, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a specialty pharmaceutical product, with a ceiling value of $11,659.62 and a period of performance through December 16, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $14,326.40 and a completion date of May 8, 2025. The contract is not set aside and involves the procurement of HYPERRAB 300 UNIT/ML VIAL 5ML, a medical product. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,308.34, is for the delivery of HYPERRAB 300 UNIT/ML VIAL 3ML, a specialized medical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $69,602.94, is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a specialized medical product. The contract has an ultimate completion date of July 14, 2025 and was awarded on June 20, 2025. This contract is not set-aside and is open to full and open competition. Amerisourcebergen Drug...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HYPERRAB 300UNIT/ML 1S, a medical product, with a ceiling value of $9,304.50 and a completion date of May 7, 2024. The contract is Firm Fixed Price and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product. The contract has a firm fixed price of $10,744.80 and a completion date of June 3, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB24FLHN0
    Delivery Order

This is a delivery order for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a firm-fixed price contract with a ceiling value of $3,756.72 and a completion date of September 27, 2024. The contract does not have a set-aside designation. As one of Amerisourcebergen's numerous federal contract awards, this delivery order is likely part of the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a wide range of medical commodities to support military healthcare programs.

Generated 12/6/24, 9:33 AM